Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      NBA Europe talks at an impasse, adding uncertainty to bidding process

      Unfortunately, the article title and content are missing, making it difficult to generate a specific and contextually rele...

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      NBA Europe talks at an impasse, adding uncertainty to bidding process

      Unfortunately, the article title and content are missing, making it difficult to generate a specific and contextually rele...

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      What’s on in London in May

      City skyline view with modern skyscrapers under a clear blue sky in May, reflecting urban growth and economic vibrancy

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper
  • ISA Guide
  • Sign In
  • Sign Out
  • My Account

pascal soirot

  • Astrazeneca ploughs £300m into UK in surprise U-turn

    Pharma

    British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab after getting in a spat with the UK government over drug pricing. In a stunning volte-face, the UK’s largest pharmaceutical company said it would revive its £200m investment into a megalab [...]

    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca chief blasts Europe for ‘putting citizens’ health at risk’

    healthcare

    Europe is putting its “ability to protect the health of its own people at risk” by not investing enough, the chief executive of FTSE 100 giant Astrazeneca has warned. Pascal Soriot added that the continent is “falling behind” in attracting R&D and manufacturing investment and needs to “invest more in what really matters to it”. [...]

    The CEO of FTSE 100 giant Astrazeneca has spoken out. (Photo by Christopher Furlong/Getty Images)
  • How much is too much? The CEO pay predicament

    Pay

    A growing number of London-listed companies have been asking shareholders to approve radical pay rises for their top execs. Why?

    CEO pay is once again a hot topic in the City, but how much is too much?

Trending Articles

  • Jet fuel shortage looms as government scrambles to secure supplies

  • John Lewis hit with click-and-collect lawsuit 

  • JP Morgan shifts Paris jobs back to London in Brexit shake-up

  • Mark Kleinman: Is it lights out for Ovo Energy?

  • Pension industry 1-0 Torsten Bell

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited